Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is held by 197 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 14,216,976 | 7,506,782 | 111.87% | $212,026,862.00 |
| FMR LLC | 31 Mar, 2026 | 10,386,845 | 5,363,753 | 106.78% | $154,867,859.00 |
| Bain Capital Life Sciences Investors, LLC | 31 Mar, 2026 | 8,508,641 | 1,664,687 | 24.32% | $212,716,025.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 8,020,576 | 476,404 | 6.31% | $119,586,788.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 7,544,172 | 750,000 | 11.04% | $188,604,300.00 |
| Bain Capital Life Sciences Investors, LLC | 31 Mar, 2026 | 7,473,238 | -1,035,403 | -12.17% | $111,425,979.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 6,710,194 | 3,124,345 | 87.13% | $167,901,108.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,652,135 | 88,875 | 1.60% | $84,273,331.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,563,260 | 836,866 | 17.71% | $139,081,500.00 |
| BVF INC/IL | 31 Mar, 2026 | 5,295,893 | 0 | 0.00% | $78,961,765.00 |
| BVF INC/IL | 31 Mar, 2026 | 5,295,893 | 0 | 0.00% | $132,397,325.00 |
| FMR LLC | 31 Mar, 2026 | 5,023,092 | 4,993,670 | 16,972.57% | $125,577,309.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 4,756,949 | 1,456,249 | 44.12% | $70,926,110.00 |
| State Street Corp | 31 Mar, 2026 | 3,937,831 | 2,053,432 | 108.97% | $58,713,060.00 |
| Cormorant Asset Management, LP | 31 Mar, 2026 | 3,900,000 | 1,150,000 | 41.82% | $58,149,000.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 3,561,355 | 364,035 | 11.39% | $89,033,875.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 3,300,700 | 3,300,700 | 0.00% | $82,517,500.00 |
| Logos Global Management LP | 31 Mar, 2026 | 3,208,875 | 0 | 0.00% | $47,844,326.00 |
| Logos Global Management LP | 31 Mar, 2026 | 3,208,875 | 0 | 0.00% | $80,221,875.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,083,517 | 3,083,517 | 0.00% | $45,975,238.00 |